Risk modeling for ventricular assist device support in post-cardiotomy shock

Area of Science:

• Cardiology
• Cardiac Surgery
• Intensive Care Medicine

Background:

• Post-cardiotomy shock (PCS) presents complex challenges in cardiac surgery.
• Current treatments like inotropes and intra-aortic balloon pump (IABP) support improve cardiac function but often fail to prevent end-organ injury, prolonged ICU stays, and increased mortality.

Purpose of the Study:

• To identify independent risk factors for hospital mortality in patients experiencing PCS after coronary artery bypass grafting (CABG).
• To develop a predictive risk score for hospital mortality in this patient population.

Main Methods:

• A retrospective analysis of 321 patients who required IABP and inotropic support for PCS following CABG between 1997 and 2002.
• Multivariate logistic regression was used to analyze perioperative variables, including age, mixed venous saturation (MVO2), inotropic requirements, and left ventricular (LV) function.
• A risk score was developed based on significant independent predictors of mortality (p < 0.05).

Main Results:

• Overall hospital mortality was 16%.
• Independent predictors of mortality included MVO2 < 60% (OR=3.2), high-dose milrinone (OR=3.2), age > 75 (OR=2.7), and high-dose adrenaline (OR=1.5).
• A 15-point risk score demonstrated increasing mortality with higher scores: 46% for scores >6, 31% for scores 3-6, and 11% for scores <3.

Conclusions:

• Despite IABP and inotropic support, a significant proportion of PCS patients face high mortality.
• Advanced age, reliance on high-dose inotropes, and impaired oxygen delivery are key predictors of increased mortality risk.
• Further research is warranted to evaluate the potential benefit of early mechanical circulatory support, such as a ventricular assist device (VAD), in high-risk PCS patients.